• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Diagnosis of hereditary hemochromatosis with molecular analysis of DNA in patients with anti-HCV positive liver cirrhosis. Clinical case].

作者信息

Carella A M, Bianco G, Carella M, Gasparini P

机构信息

Divisione di Medicina Interna, IRCCS, Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia.

出版信息

Minerva Med. 1998 Sep;89(9):323-7.

PMID:9856121
Abstract

A case of hereditary hemochromatosis in a patient affected by anti-HCV positive liver cirrhosis is described. The difficulties for an exact diagnosis are underlined. Really, it can be particularly difficult to make a differential diagnosis between hereditary hemochromatosis and secondary hemochromatosis, if liver cirrhosis has already been found. Practically, at this stage of disease, the histological and clinical aspects of these two forms become completely interchangeable. Moreover, diagnostic difficulties increase when, at the same time, the patient presents more causes of potential liver damage. In this case report, the DNA-analysis, obtained by polymerase chain reaction amplification and enzymatic digestion, allows to make the diagnosis of hereditary hemochromatosis, because it showed the presence of two genetic mutations, considered responsible for the disease. Both the hereditary hemochromatosis and the HCV infection, had greatly contributed to the development of liver cirrhosis. In the future, DNA-analysis by amplification with polymerase chain reaction, can assume relevant importance for the screening of affected patients' first grade parents too. It could permit an early diagnosis of hereditary hemochromatosis and then to start a timelier and more efficacious therapy, to prevent an irreversible histological damage.

摘要

相似文献

1
[Diagnosis of hereditary hemochromatosis with molecular analysis of DNA in patients with anti-HCV positive liver cirrhosis. Clinical case].
Minerva Med. 1998 Sep;89(9):323-7.
2
End stage liver disease in a 13-year old secondary to hepatitis C and hemochromatosis.一名13岁儿童因丙型肝炎和血色素沉着症导致终末期肝病。
Am J Gastroenterol. 1996 Jul;91(7):1427-9.
3
Hereditary hemochromatosis masquerading as rheumatoid arthritis.
Ann Ital Med Int. 2001 Jan-Mar;16(1):46-9.
4
Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.遗传性血色素沉着症相关的肝细胞癌发生于非肝硬化肝脏。
Z Gastroenterol. 2006 Jan;44(1):39-42. doi: 10.1055/s-2005-858567.
5
Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.隐匿性乙型肝炎病毒感染和既往乙型肝炎病毒感染对丙型肝炎病毒所致肝硬化患者肝细胞癌发生的影响
Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.
6
Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients.1948 - 1985年丹麦临床显性遗传性血色素沉着症:179例患者的流行病学、长期生存的相关因素及死因
Ann Hematol. 2001 Dec;80(12):737-44. doi: 10.1007/s002770100371. Epub 2001 Oct 11.
7
[A new method of molecular testing in the differential diagnosis of hereditary hemochromatosis].[一种用于遗传性血色素沉着症鉴别诊断的分子检测新方法]
Orv Hetil. 1999 Nov 7;140(45):2517-22.
8
High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.丙型肝炎病毒1b型感染患者移植后同种异体移植肝硬化的高发病率:与排斥反应的关系。
Hepatology. 1999 Jan;29(1):250-6. doi: 10.1002/hep.510290122.
9
Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.丙型肝炎病毒感染的肾移植受者中的纤维化胆汁淤积性肝炎
Liver Transpl Surg. 1999 Jul;5(4):294-300. doi: 10.1002/lt.500050417.
10
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析:一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.